FoRx Therapeutics
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$60.85M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
FoRx Therapeutics is a biotechnology company that develops a new generation of first-in-class oral small molecule cancer drugs focusing on novel DNA Replication Stress pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FoRx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
FoRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Seed | Apr 22, 2020 |
FoRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Omega Funds | Seed |
| EQT Life Sciences | Seed, Series A |
| M Ventures | Series A, Seed |
| Pfizer Ventures | Seed, Series A |
| Pfizer | Seed, Series A |
| Pfizer Ventures | Seed, Series A |
| M Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
FORX-428 shows potential for best-in-class PARG inhibition.
- Mar 26, 2026
Presented preclinical data for FORX-428 at ACS Spring 2026.
FoRx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about FoRx Therapeutics's valuation, stock price, and market status.